Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results)-Reference-Cited by-同舟云学术

Frequency of occurrence of type 2 diabetes and metabolic disturbances in patients with schizophrenic range disorders with prolonged anti-relapse antipsychotic therapy (based on screening results)

Published:2019-07-11 Issue:2 Volume: Page:37-45
ISSN:2313-7053
Container-title:V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
language:
Short-container-title:V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY

Author:

Gorobets L. N.¹,Tsarenko M. A.²,Litvinov A. V.¹,Vasilenko L. M.¹

Affiliation:

1. Moscow Research Institute of Psychiatry, Branch of National Medical Research Center of Psychiatry and Narcology of Health Ministry of Russia

2. Moscow City Psycho-Endocrinological Center

Abstract

The article presents the results of screening data from a simultaneous study of 443 outpatient cards of patients with schizophrenic spectrum disorders who were under dynamic outpatient monitoring in two areas of the psycho-neurological dispensary No. 2 in Moscow in order to assess the incidence of type 2 diabetes mellitus (T2DM), and also metabolic disorders (MD) in patients with prolonged anti-relapse antipsychotic therapy. The incidence of these disorders as a whole was 24.6%. Differences in the prevalence of diabetes mellitus 2 and MN were considered depending on the gender of the patient and the antipsychotic used. The obtained data on the high frequency of occurrence of the above metabolic disorders indicate the need to develop standards for antipsychotic therapy of patients with schizophrenic spectrum disorders when combined with T2DM and MD.

Publisher

V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology

Reference35 articles.

1. Alfimov V.P., Ryvkin P.V., Ladyzhenskij M.Ya. i dr. Metabolicheskij sindrom u bol’nyh shizofreniej (obzor literatury) // Sovremennaya terapiya psihicheskih rasstrojstv. 2014. № 3. S. 8-15.

2. Ametov A.S., Bogdanova L.N. Giperglikemiya i glyukozotoksich nost’ — klyuchevye faktory progressirovaniya saharnogo diabeta 2-go tipa // Russkij medicinskij zhurnal. Endokrinologiya. 2010. T. 18, № 23. S. 1416-1422.

3. Gorobets L.N. Nejroehndokrinnye disfunkcii i nejrolepticheskaya terapiya. M.: Medpraktika. 2007. 312 s.

4. Gorobets L.N., Bulanov V.S., Vasilenko L.M., Litvinov A.V., Polyakovskaya T.P. Metabolicheskie rasstrojstva u bol’nyh shizofreniej v processe terapii atipichnymi antipsihoticheskimi preparatami // Zhurnal nevrologii i psihiatrii im. S.S.Korsakova. 2012. Tom 112, №9. S. 90-96.

5. Gorobets L.N., Litvinov A.V., Polyakovskaya T.P. Problemy somaticheskogo zdorov’ya u psihicheski bol’nyh: saharnyj diabet 2 tipa // Social’naya i klinicheskaya psihiatriya. 2013. Tom 23, vypusk 4. S. 62-75.